ExecutiveOrdersEO
EO 14355Executive OrderTrump 47 · R

Executive Order 14355

Unlocking Cures for Pediatric Cancer With Artificial Intelligence

This executive order directs the Make America Healthy Again (MAHA) Commission and health agencies to leverage artificial intelligence to accelerate pediatric cancer research, diagnosis, and treatment. It builds on the existing Childhood Cancer Data Initiative (CCDI) by mandating AI-driven improvements to data infrastructure, clinical trial design, and interoperability standards while prioritizing federal investment and private-sector engagement.

Federal Register Open PDF 90 FR 48153

Impact dates

  1. Initial focus on identifying opportunities to accelerate AI-driven solutions at CCDI

Market exposure

Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

Sectors

Technology & softwarePharmaOther industrial

Mechanisms

Subsidy / incentiveProcurement

Role pressure

  • ProtectiveDomestic producer — AI and health technology firms developing pediatric oncology tools receive federal prioritization and research funding incentives
  • MixedDownstream manufacturer — Pharma and biotech companies gain access to improved clinical trial infrastructure and data but face pressure to adopt AI and share data interoperably
  • ProtectiveProject developer — NCI-Designated Cancer Centers receive prioritized funding for AI-driven research projects and data platform expansion

Geographies

US

Illustrative public companies

Curated watchlist matches by sector/role — incomplete; not a recommendation.

MMM3MGOOGLAlphabetAAPLAppleCATCaterpillarLLYEli LillyFCXFreeport-McMoRanGEVGE VernovaHONHoneywellQQQInvesco QQQ TrustJNJJohnson & JohnsonMRKMerckMETAMeta PlatformsMSFTMicrosoftNVSNovartisNVDANVIDIAORCLOraclePFEPfizerSPYSPDR S&P 500 ETF

Confidence: medium · Policy alerts

Key directives

  • MAHA Commission to coordinate with Secretary of HHS, APST, and Special Advisor for AI and Crypto to develop AI applications for pediatric cancer
  • Initial focus on accelerating AI-driven solutions at CCDI including data platforms and research funding at NCI-Designated Cancer Centers
  • Secretary of HHS to finalize interoperability standards for AI-enabled patient data with appropriate privacy protections
  • Director of OMB, NIH Director, and APST to coordinate on expanding pediatric cancer research investment strategies
  • Private sector encouraged to utilize advanced AI technologies for pediatric cancer to maximum extent

Who is ordered

Timeline

Immediate

  • MAHA Commission coordination with HHS Secretary, APST, and Special Advisor for AI and Crypto begins
  • Focus on accelerating AI-driven solutions at CCDI

Near term (90d)

  • Identification of opportunities to expand CCDI data platforms and tools
  • Prioritization of AI research projects at NCI-Designated Cancer Centers
  • Development of interoperability standards for AI-enabled patient data

Long term

  • Potential transformation of pediatric cancer care and research infrastructure
  • Expanded federal and private investment in AI-enabled pediatric cancer solutions
  • Integration of multimodal data into clinical practice and trial design

Risks & tensions

  • Order is aspirational and coordination-heavy with few hard deadlines; implementation depends on appropriations and interagency cooperation
  • Privacy protections for pediatric health data are mentioned but specific standards are undefined
  • Reliance on 'existing Federal funds' (Sec. 3(a)) suggests no new mandatory spending, creating tension with ambitious goals
  • Potential overlap or conflict with broader AI governance frameworks and state-level health data privacy laws
Executive Order 14355: Unlocking Cures for Pediatric Cancer With Artificial Intelligence · Executive Orders